ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1476

Improvement of the Long-Term Outcome in Greek Adult Patients with Juvenile Idiopathic Arthritis in the 21st Century

Despoina Dimopoulou1, Maria Trachana2, Polyxeni Pratsidou-Gertsi2, Prodromos Sidiropoulos3, Athina Theodoridou1, Florence Kanakoudi-tsakalidou2 and Alexandros Garyfallos1, 14th Department of Internal Medicine, Aristotle University, Thessaloniki, Greece, 21st Department of Pediatrics, Aristotle University, Thessaloniki, Greece, 3Rheumatology, University of Crete, Medical School, Heraklion, Greece

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Juvenile idiopathic arthritis (JIA) and outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: During the last decade there is evidence of a rising improvement regarding the long-term outcome of patients with Juvenile Idiopathic Arthritis (JIA). The aim of the study was to compare long-term outcome between patients with disease onset before and after 2000. 

Methods: Patients (pts) > 18 years with an established JIA, a disease onset >5 years and no history of > 6 months care from external rheumatologists, were enrolled in the study. Clinical, laboratory and radiographic examination were performed at the last follow-up visit, 17.2 years post-diagnosis. The outcome variables were: radiographic damage assessed by the Total modified Sharp/van der Heijde Score (TmSvdHS), articular and extra-articular damage by Juvenile Arthritis Damage Index (JADI-A and JADI-E) and physical ability by the Health Assessment Questionnaire-Disability Index (HAQ-DI). In the multivariate analysis, possible explanatory variables were characteristics present at onset and active disease duration within 5 years of onset. 

Results: A total of 102 (72 F) pts were enrolled. The age at disease onset (mean ±SD) was 7.7 ±4 yrs, the interval from onset to last visit 17.2 ±6.7 yrs and the pts’ current  age 25 ±5.9 yrs. Twenty eight patients were diagnosed after 2000 (Group 1) and 74 patients before 2000 (Group 2). The 2 Groups didn’t differ in demographic and clinical characteristics, as gender, type of disease onset and ACPA positivity. At the last follow-up visit, Group 1 had better TmSvdHS,  better JADI-A  and  better JADI-E score as compared to Group 2 (p<0.001, p<0.001, p=0.003, respectively).  In contrast, HAQ-DI score did not differ between the 2 Groups (p=0.55). Disease duration within 5 yrs of onset was longer in Group 2 (p=0.02). In the multivariate analysis, disease duration within 5 yrs of onset was a prognostic factor for joint damage [B (95%CI) 2.114 (0.206,4.022), p=0.03], cumulative % time spent in a state of active disease [B (95%CI) 0.007 (0.004,0.011), p<0.001] and cumulative time spent in a state of clinical remission off medication over the entire disease course [B (95%CI) -0.667 (-1.048,-0.286), p=0.001].

Conclusion: Patients diagnosed after 2000, had a better long term outcome as compared to those before 2000. Despite the difference in disease duration, active disease duration within 5 years of onset proved to be a critical prognostic factor, probably reflecting the availability of biologics nowadays and the treat-to-target strategies.


Disclosure: D. Dimopoulou, None; M. Trachana, None; P. Pratsidou-Gertsi, None; P. Sidiropoulos, None; A. Theodoridou, None; F. Kanakoudi-tsakalidou, None; A. Garyfallos, None.

To cite this abstract in AMA style:

Dimopoulou D, Trachana M, Pratsidou-Gertsi P, Sidiropoulos P, Theodoridou A, Kanakoudi-tsakalidou F, Garyfallos A. Improvement of the Long-Term Outcome in Greek Adult Patients with Juvenile Idiopathic Arthritis in the 21st Century [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/improvement-of-the-long-term-outcome-in-greek-adult-patients-with-juvenile-idiopathic-arthritis-in-the-21st-century/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improvement-of-the-long-term-outcome-in-greek-adult-patients-with-juvenile-idiopathic-arthritis-in-the-21st-century/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology